184 related articles for article (PubMed ID: 21626669)
21. Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: Harboring clues to pathogenesis?
Moog U; Roelens F; Mortier GR; Sijstermans H; Kelly M; Cox GF; Robson CD; Kimonis VE
Am J Med Genet A; 2007 Dec; 143A(24):2973-80. PubMed ID: 18000896
[TBL] [Abstract][Full Text] [Related]
22. Neuroimaging Findings in Encephalocraniocutaneous Lipomatosis.
Michael GA; Poretti A; Huisman TA
Pediatr Neurol; 2015 Nov; 53(5):462-3. PubMed ID: 26344330
[No Abstract] [Full Text] [Related]
23. Encephalocraniocutaneous lipomatosis.
Gawel J; Schwartz RA; Józwiak S
J Cutan Med Surg; 2003; 7(1):61-5. PubMed ID: 12362260
[TBL] [Abstract][Full Text] [Related]
24. Neurocutaneous melanosis in association with encephalocraniocutaneous lipomatosis.
Ahmed I; Tope WD; Young TL; Miller DM; Bloom KE
J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S196-200. PubMed ID: 12140461
[TBL] [Abstract][Full Text] [Related]
25. Giant Ocular Lipodermoid Cyst in Encephalocraniocutaneous Lipomatosis: Surgical Treatment and Genetic Analysis.
Córdoba A; Graue-Hernández EO; Navas A; Chacon-Camacho OF; Zenteno JC; Ramirez-Miranda A; Bermudez-Magner JA; Ordaz-Robles T; Pérez-Solórzano S; Olivo-Payne A
Am J Case Rep; 2019 Oct; 20():1566-1571. PubMed ID: 31649234
[TBL] [Abstract][Full Text] [Related]
26. Encephalocraniocutaneous lipomatosis with neurocutaneous melanosis.
Jain P; Chakrabarty B; Kumar A; Gupta N; Kabra M; Gulati S
J Child Neurol; 2014 Jun; 29(6):846-9. PubMed ID: 23620525
[TBL] [Abstract][Full Text] [Related]
27. Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.
McDonell LM; Leung GK; Daoud H; Ip J; Chim S; Luk HM; Lan L; ; Boycott KM; Chung BH
Am J Med Genet A; 2018 Nov; 176(11):2523-2527. PubMed ID: 30289595
[No Abstract] [Full Text] [Related]
28. Encephalocraniocutaneous lipomatosis: a case report and review of the literature.
Chandravanshi SL
Indian J Ophthalmol; 2014 May; 62(5):622-7. PubMed ID: 24881613
[TBL] [Abstract][Full Text] [Related]
29. Encephalocraniocutaneous Lipomatosis Associated with Orbital Cyst: A Variant or New Entity?
Farouk AG; Farate A; Musa ZY; Zarami AB; Kachallah Monguno HF
Turk J Ophthalmol; 2021 Feb; 51(1):66-69. PubMed ID: 33631921
[TBL] [Abstract][Full Text] [Related]
30. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis.
Nowaczyk MJ; Mernagh JR; Bourgeois JM; Thompson PJ; Jurriaans E
Am J Med Genet; 2000 Apr; 91(4):261-6. PubMed ID: 10766980
[TBL] [Abstract][Full Text] [Related]
31. A case of encephalocraniocutaneous lipomatosis syndrome with epilepsy (Haberland syndrome).
Zahariev ZI; Peycheva MV; Dobrev HP
Folia Med (Plovdiv); 2009; 51(4):46-8. PubMed ID: 20232658
[TBL] [Abstract][Full Text] [Related]
32. Encephalocraniocutaneous lipomatosis.
Moog U
J Med Genet; 2009 Nov; 46(11):721-9. PubMed ID: 19574261
[TBL] [Abstract][Full Text] [Related]
33. Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.
Bennett JT; Tan TY; Alcantara D; Tétrault M; Timms AE; Jensen D; Collins S; Nowaczyk MJM; Lindhurst MJ; Christensen KM; Braddock SR; Brandling-Bennett H; Hennekam RCM; Chung B; Lehman A; Su J; Ng S; Amor DJ; ; ; Majewski J; Biesecker LG; Boycott KM; Dobyns WB; O'Driscoll M; Moog U; McDonell LM
Am J Hum Genet; 2016 Mar; 98(3):579-587. PubMed ID: 26942290
[TBL] [Abstract][Full Text] [Related]
34. Sensitive detection of FGFR1 N546K mosaic mutation in patient with encephalocraniocutaneous lipomatosis and pilocytic astrocytoma.
Kordacka J; Zakrzewski K; Gruszka R; Witusik-Perkowska M; Taha J; Sikorska B; Liberski PP; Zakrzewska M
Am J Med Genet A; 2019 Aug; 179(8):1622-1627. PubMed ID: 31173478
[TBL] [Abstract][Full Text] [Related]
35. Expending the Phenotypic Spectrum of Encephalocraniocutaneous Lipomatosis: About a Prenatal Case With Complete Autopsy.
Cattin J; Formet J; Sartelet H; Lenoir M; Riethmuller D; Collardeau-Frachon S
Pediatr Dev Pathol; 2022; 25(2):180-185. PubMed ID: 34547955
[TBL] [Abstract][Full Text] [Related]
36. Low-grade astrocytoma in a child with encephalocraniocutaneous lipomatosis.
Brassesco MS; Valera ET; Becker AP; Castro-Gamero AM; de Aboim Machado A; Santos AC; Scrideli CA; Oliveira RS; Machado HR; Tone LG
J Neurooncol; 2010 Feb; 96(3):437-41. PubMed ID: 19652916
[TBL] [Abstract][Full Text] [Related]
37. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
[TBL] [Abstract][Full Text] [Related]
38. [Encephalocraniocutaneous lipomatosis and didymosis aplasticopsilolipara].
Martí N; Alonso V; Jordá E
Actas Dermosifiliogr; 2012 May; 103(4):341-2. PubMed ID: 22192510
[No Abstract] [Full Text] [Related]
39. Encephalocraniocutaneous lipomatosis with Wilms' tumor.
Damar Ç; Yaman A; Ali İkidağ M; Pekpak E; Olgaç A
Pediatr Int; 2017 Jul; 59(7):835-836. PubMed ID: 28612492
[No Abstract] [Full Text] [Related]
40. Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome.
Brown KE; Goldstein SM; Douglas RS; Katowitz JA
J AAPOS; 2003 Apr; 7(2):148-9. PubMed ID: 12736631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
